These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4039448)

  • 1. Sequential cis-platinum and VM26 in neuroblastoma: laboratory and clinical (OPEC regimen) studies.
    Pritchard J; Whelan R; Hill BT
    Prog Clin Biol Res; 1985; 175():545-55. PubMed ID: 4039448
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
    Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
    Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypersensitivity to VM-26].
    Köster B; Ritter J; Bode U
    Klin Padiatr; 1984; 196(3):178-80. PubMed ID: 6540829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboplatin activity in cisplatin treated neuroblastoma.
    Lewis IJ; Stevens MC; Pearson AD; Pinkerton CR; Barnes JM
    Prog Clin Biol Res; 1991; 366():553-9. PubMed ID: 2068173
    [No Abstract]   [Full Text] [Related]  

  • 5. Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.
    Shafford EA; Rogers DW; Pritchard J
    J Clin Oncol; 1984 Jul; 2(7):742-7. PubMed ID: 6539811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of sequentially scheduled cisplatin and VM26 in neuroblastoma: response and toxicity.
    Hayes FA; Green AA; Casper J; Cornet J; Evans WE
    Cancer; 1981 Oct; 48(8):1715-8. PubMed ID: 7197189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of cis-dichlorodiammine-platinum in the treatment of advanced neuroblastoma].
    Ohnuma N; Takahashi H; Maie M; Etoh T; Tanabe M; Kuriyama Y
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2876-80. PubMed ID: 3662544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
    Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
    Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single center experience with bone marrow transplantation for high risk neuroblastoma.
    Ladenstein R; Lasset C; Bouffet E; Brunat-Mentigny M; Biron P; Philip I; Chauvin F; Philip T
    Bone Marrow Transplant; 1991; 7 Suppl 2():93. PubMed ID: 1878741
    [No Abstract]   [Full Text] [Related]  

  • 10. Teniposide: a review of 12 years of experience.
    O'Dwyer PJ; Alonso MT; Leyland-Jones B; Marsoni S
    Cancer Treat Rep; 1984 Dec; 68(12):1455-66. PubMed ID: 6391663
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroblastoma.
    Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is more better? Dose intensity in neuroblastoma.
    Anderson JR; Coccia PF
    J Clin Oncol; 1991 Jun; 9(6):902-4. PubMed ID: 2033426
    [No Abstract]   [Full Text] [Related]  

  • 13. Vincristine, cisplatin, teniposide, and cyclophosphamide combination in the treatment of recurrent or metastatic adrenocortical cancer.
    Khan TS; Sundin A; Juhlin C; Wilander E; Oberg K; Eriksson B
    Med Oncol; 2004; 21(2):167-77. PubMed ID: 15299189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma.
    De Bernardi B; Nicolas B; Boni L; Indolfi P; Carli M; Cordero Di Montezemolo L; Donfrancesco A; Pession A; Provenzi M; di Cataldo A; Rizzo A; Tonini GP; Dallorso S; Conte M; Gambini C; Garaventa A; Bonetti F; Zanazzo A; D'Angelo P; Bruzzi P;
    J Clin Oncol; 2003 Apr; 21(8):1592-601. PubMed ID: 12697885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
    Mastrangelo S; Tornesello A; Diociaiuti L; Pession A; Prete A; Rufini V; Troncone L; Mastrangelo R
    Br J Cancer; 2001 Feb; 84(4):460-4. PubMed ID: 11207038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of patients with advanced neuroblastoma surviving more than 5 years after initiation of an intensive Japanese protocol: a report from the Study Group of Japan for Treatment of Advanced Neuroblastoma.
    Iwafuchi M; Utsumi J; Tsuchida Y; Kaneko M; Matsuyama S; Ohnuma N; Taguchi N; Mugishima H; Yokoyama J; Sasaki S; Yoshioka A; Nagahara N; Fukuzawa M; Suita S
    Med Pediatr Oncol; 1996 Dec; 27(6):515-20. PubMed ID: 8888810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of cisplatin in children with malignant solid tumors. Pediatric Cisplatin Study Group].
    Suganuma Y; Ise T; Akiyama Y; Bessho F; Fukazawa K; Hirotsu T; Kitamura T; Koide A; Matsuyama K; Muchi H
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3083-90. PubMed ID: 3674893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.
    Cheung NK; Kushner BH; LaQuaglia M; Kramer K; Gollamudi S; Heller G; Gerald W; Yeh S; Finn R; Larson SM; Wuest D; Byrnes M; Dantis E; Mora J; Cheung IY; Rosenfield N; Abramson S; O'Reilly RJ
    Med Pediatr Oncol; 2001 Jan; 36(1):227-30. PubMed ID: 11464891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of age.
    Tweddle DA; Pinkerton CR; Lewis IJ; Ellershaw C; Cole M; Pearson AD
    Med Pediatr Oncol; 2001 Jan; 36(1):239-42. PubMed ID: 11464894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide/doxorubicin vs. cisplatin/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: a Pediatric Oncology Group Randomized Phase II study.
    McWilliams NB; Hayes FA; Green AA; Smith EI; Nitschke R; Altshuler GA; Shuster JJ; Castleberry RP; Vietti TJ
    Med Pediatr Oncol; 1995 Mar; 24(3):176-80. PubMed ID: 7838039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.